BioCorRx Pharmaceuticals Inc a subsidiary of BioCorRx Inc (OTC: BICX) Employee Directory

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

BioCorRx Pharmaceuticals Inc., a subsidiary of BioCorRx Inc., operates in the pharmaceutical manufacturing sector with a focus on addiction-related conditions. It is a clinical-stage and commercial biopharmaceutical company developing treatments for opioid use disorder and alcohol use disorder to support long-term recovery and wellness.

Its lead candidate, BICX104, is an implantable, sustained-release naltrexone formulation designed to improve patient adherence and reduce relapse risk as it advances toward potential FDA approval. The company is based in Anaheim, California, and operates with a small team. In 2025, BioCorRx expanded its portfolio by entering into a definitive agreement to acquire LUCEMYRA, an FDA-approved medication for opioid withdrawal, signaling a broader product offering.

Sign up for free to view info

Company overview Email format